IDEAYA Biosciences, Inc. IDYA Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s investment proceeds?
- IDEAYA Biosciences, Inc. (IDYA) reported investment proceeds of $162.53M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s investment proceeds changed year-over-year?
- IDEAYA Biosciences, Inc.'s investment proceeds decreased by 12.8% year-over-year, from $186.35M to $162.53M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s investment proceeds?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s investment proceeds has grown at a 260.7% compound annual growth rate (CAGR), from $4.02M to $680.23M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.